Project Grant 2131777
Award Date
2/15/22
Completion Date
1/31/23
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Awardee
Circulatech LLC (YP7WJGXFNGP5)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Miramar, FL 33029, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $790,738 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Circulatech LLC, a for-profit limited liability company located in Pembroke Pines, FL. The purpose of this project is to develop and validate Circulatech's "ThoraFlush" device, a proactive chest tube designed to maintain patency and prevent clotting in over 455,000 annual...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $275,000 awarded to Xtract Medical Inc. aims to develop and demonstrate the feasibility of a novel catheter-based system for improved removal of blood clots during mechanical thrombectomy procedures to treat venous thromboembolism (VTE). The proposed system is designed to effectively remove large blood clots while minimizing damage to blood vessels and reducing complications such as...
This federal Project Grant award from the National Science Foundation's Division of Civil, Mechanical, and Manufacturing Innovation (CFDA 47.041 - Engineering) provides $500,000 in funding to North Carolina State University to conduct fundamental research aimed at reducing blood clotting in medical devices. The key products and services to be delivered under this award include: 1) molecular dynamics simulations and interfacial spectroscopy to understand the role of hydration layers in preventing...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop and test a drug-eluting chest tube to locally manage the pain associated with its use in cardiothoracic surgeries. The $275,752 award supports two key objectives: 1) completing GMP/GLP studies on the drug release kinetics, stability, and manufacturing of the drug-releasing chest tube; and 2) evaluating the mechanical...
This $1,199,991 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program aims to develop novel technologies for real-time assessment of blood clot properties to improve stroke treatment. The key products and services under this grant include: Integration of a sub-millimeter Raman fiber probe into a catheter for intravascular, in-vivo measurement of clot chemical composition. Training of a convolutional neural network to...
This $240,412 Project Grant award from the National Science Foundation (NSF) Engineering Program (CFDA 47.041) supports collaborative research at East Carolina University (ECU) to investigate how tension affects the digestion of blood clots. The research aims to test hypotheses about how inherent and applied tension on fibrin fibers impact the fibrinolysis process, which is essential for the proper dissolution of blood clots to prevent risks like strokes and heart attacks. The...
The National Science Foundation awarded Juggernaut Life Sciences LLC a $256,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a smart, semi-autonomous fluid drainage system for surgical procedures. The one-year project will create a prototype robotic device with integrated ultrasound probe, anesthetic syringe, scalpel, and aspiration needle to demonstrate the feasibility of semi-autonomously performing paracentesis procedures to drain...
This Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) supports research to advance the understanding and modeling of thrombus (clot) formation and its response to external loads in blood vessels. The $506,803 award, with a project period from October 1, 2024 to October 31, 2029, will fund the development of multiscale modeling tools using powerful computers and artificial intelligence to better predict clot growth and its response to pulsatile...
This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, provides $920,176 under the Cardiovascular Diseases Research program to develop a smart aspiration catheter with fiber optic pressure sensors for mechanical thrombectomy procedures to treat acute ischemic stroke. The catheter will be designed, prototyped and validated at Worcester Polytechnic Institute to provide real-time data to interventionalists on the interaction...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), awarded a $595,464 Project Grant to Cerulean Scientific Inc. on September 25, 2024. The funding supports the development and commercialization of Cerulean Scientific's tethered liquid perfluorocarbon (TLP) coating technology for peripheral vascular grafts (PVGs). The key objectives are to evaluate the durability, anti-fouling properties, and thrombogenicity of...